Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer

Mycobacterium bovis bacillus Calmette–Guerin (BCG) remains at the forefront of immunotherapy for treating bladder cancer patients. However, the incidence of recurrence and progression to invasive cancer is commonly observed. There are no established effective intravesical therapies available for pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Buss, Julieti Huch, Begnini, Karine Rech, Bender, Camila Bonemann, Pohlmann, Adriana R., Guterres, Silvia S., Collares, Tiago, Seixas, Fabiana Kömmling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770893/
https://www.ncbi.nlm.nih.gov/pubmed/29379438
http://dx.doi.org/10.3389/fphar.2017.00977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770893/
https://www.ncbi.nlm.nih.gov/pubmed/29379438
http://dx.doi.org/10.3389/fphar.2017.00977

Ejemplares similares